1024免费一级欧美片在线观看_久久免费精品视频互動交流_国国产无套粉嫩白浆在线_饥渴难耐的浪荡艳妇_亚洲国产日韩一区在线_欧美激情性爱吧_精品人妻少妇av嫩草_嗯啊不要视频_另类欧美亚洲综合_网友自拍亚洲无码另类

杭州昊鑫生物科技股份有限公司
網(wǎng)站標(biāo)題
搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

杭州昊鑫生物科技股份有限公司
    當(dāng)前位置:
  • 首頁>
  • 產(chǎn)品中心>
  • MCE>
  • Doxycycline...

產(chǎn)品中心

Doxycycline (hyclate)

分享到微信

×
Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) 是一種四環(huán)素抗生素,口服有效的,廣譜的金屬蛋白酶 (MMP) 抑制劑,具有抗菌活性。
貨號:HY-N0565B
CAS:24390-14-5
參數(shù)品牌:MCE
產(chǎn)品參數(shù)
品牌:MCE
型號:HY-N0565B
起訂量:1
規(guī)格::5g
價格::¥750
我知道了
在線客服
產(chǎn)品詳情

Doxycycline (hyclate)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) 是一種四環(huán)素抗生素,口服有效的,廣譜的金屬蛋白酶 (MMP) 抑制劑,具有抗菌活性。


生物活性

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate), an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]


體外研究(In Vitro)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) affects growth of glioma cells only under high concentrations[2].

Doxycycline (hyclate) decreases MT-CO1 protein content with concentrations of 1 μg/mL and higher in SVG cells[2].
Doxycycline (1 μg/mL) induce short-hairpin RNA (shRNA) expression in H23 cells[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[2]

Cell Line:LNT-229, G55, and U343 glioma cells
Concentration:0.01, 0.1, 1, or 10 μg/mL
Incubation Time:4 days
Result:Affected growth of glioma cells only under high concentrations.


體內(nèi)研究(In Vivo)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) (oral; 200 or 800 mg/kg/day; for 3 months) reduces active MMP-9 in untreated HT mice in a dose-dependent manner[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:6-month-old female Heterozygous Col3a1-deficient (HT) mice[1]
Dosage:200 or 800 mg/kg
Administration:Oral; per day; for 3 months
Result:Reduced active MMP-9 in a dose-dependent manner.



分子量:512.94


Formula:C22H24N2O8.1/2C2H6O.ClH.1/2H2O


CAS 號:24390-14-5


中文名稱:多西環(huán)素鹽酸鹽半乙醇半水合物;強力霉素鹽酸鹽半乙醇半水合物


運輸條件:Room temperature in continental US; may vary elsewhere.


儲存方式:

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)


溶解性數(shù)據(jù)

DMSO : 240 mg/mL (467.89 mM; Need ultrasonic)

H2O : 125 mg/mL (243.69 mM; Need ultrasonic)

配制儲備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.9495 mL9.7477 mL19.4955 mL
5 mM0.3899 mL1.9495 mL3.8991 mL
10 mM0.1950 mL0.9748 mL1.9495 mL
*

請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 儲存時,請在 6 個月內(nèi)使用,-20°C 儲存時,請在 1 個月內(nèi)使用。

In Vivo:

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:

——為保證實驗結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實驗的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

  • 1.


    請依序添加每種溶劑: PBS

    Solubility: 20 mg/mL (38.99 mM); Clear solution; Need ultrasonic


  • 2.


    請依序添加每種溶劑: 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution


  • 3.


    請依序添加每種溶劑: 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution

參考文獻(xiàn):

[1]. Wilfried Briest, et al. Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther. 2011 Jun;337(3):621-7.

[2]. Luger AL, et al. Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. Int J Mol Sci. 2018 May 17;19(5).

[3]. Eusebio Manchado, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. 2016 Jun 30;534(7609):647-51.







Doxycycline (hyclate)

Doxycycline (hyclate)

分享到微信

×
Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) 是一種四環(huán)素抗生素,口服有效的,廣譜的金屬蛋白酶 (MMP) 抑制劑,具有抗菌活性。
貨號:HY-N0565B
CAS:24390-14-5
品牌:MCE
型號:HY-N0565B
起訂量:1
規(guī)格::5g
價格::¥750
15906629305
在線客服
產(chǎn)品詳情

Doxycycline (hyclate)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) 是一種四環(huán)素抗生素,口服有效的,廣譜的金屬蛋白酶 (MMP) 抑制劑,具有抗菌活性。


生物活性

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate), an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]


體外研究(In Vitro)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) affects growth of glioma cells only under high concentrations[2].

Doxycycline (hyclate) decreases MT-CO1 protein content with concentrations of 1 μg/mL and higher in SVG cells[2].
Doxycycline (1 μg/mL) induce short-hairpin RNA (shRNA) expression in H23 cells[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[2]

Cell Line:LNT-229, G55, and U343 glioma cells
Concentration:0.01, 0.1, 1, or 10 μg/mL
Incubation Time:4 days
Result:Affected growth of glioma cells only under high concentrations.


體內(nèi)研究(In Vivo)

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) (oral; 200 or 800 mg/kg/day; for 3 months) reduces active MMP-9 in untreated HT mice in a dose-dependent manner[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:6-month-old female Heterozygous Col3a1-deficient (HT) mice[1]
Dosage:200 or 800 mg/kg
Administration:Oral; per day; for 3 months
Result:Reduced active MMP-9 in a dose-dependent manner.



分子量:512.94


Formula:C22H24N2O8.1/2C2H6O.ClH.1/2H2O


CAS 號:24390-14-5


中文名稱:多西環(huán)素鹽酸鹽半乙醇半水合物;強力霉素鹽酸鹽半乙醇半水合物


運輸條件:Room temperature in continental US; may vary elsewhere.


儲存方式:

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)


溶解性數(shù)據(jù)

DMSO : 240 mg/mL (467.89 mM; Need ultrasonic)

H2O : 125 mg/mL (243.69 mM; Need ultrasonic)

配制儲備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.9495 mL9.7477 mL19.4955 mL
5 mM0.3899 mL1.9495 mL3.8991 mL
10 mM0.1950 mL0.9748 mL1.9495 mL
*

請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 儲存時,請在 6 個月內(nèi)使用,-20°C 儲存時,請在 1 個月內(nèi)使用。

In Vivo:

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:

——為保證實驗結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實驗的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

  • 1.


    請依序添加每種溶劑: PBS

    Solubility: 20 mg/mL (38.99 mM); Clear solution; Need ultrasonic


  • 2.


    請依序添加每種溶劑: 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution


  • 3.


    請依序添加每種溶劑: 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution

參考文獻(xiàn):

[1]. Wilfried Briest, et al. Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther. 2011 Jun;337(3):621-7.

[2]. Luger AL, et al. Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. Int J Mol Sci. 2018 May 17;19(5).

[3]. Eusebio Manchado, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. 2016 Jun 30;534(7609):647-51.







選擇區(qū)號